1. Home
  2. BDTX vs RMR Comparison

BDTX vs RMR Comparison

Compare BDTX & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • RMR
  • Stock Information
  • Founded
  • BDTX 2014
  • RMR 1986
  • Country
  • BDTX United States
  • RMR United States
  • Employees
  • BDTX N/A
  • RMR N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • RMR Professional Services
  • Sector
  • BDTX Health Care
  • RMR Consumer Discretionary
  • Exchange
  • BDTX Nasdaq
  • RMR Nasdaq
  • Market Cap
  • BDTX 220.3M
  • RMR 253.9M
  • IPO Year
  • BDTX 2020
  • RMR N/A
  • Fundamental
  • Price
  • BDTX $3.84
  • RMR $14.91
  • Analyst Decision
  • BDTX Strong Buy
  • RMR
  • Analyst Count
  • BDTX 6
  • RMR 0
  • Target Price
  • BDTX $10.17
  • RMR N/A
  • AVG Volume (30 Days)
  • BDTX 1.1M
  • RMR 216.8K
  • Earning Date
  • BDTX 11-06-2025
  • RMR 11-12-2025
  • Dividend Yield
  • BDTX N/A
  • RMR 12.01%
  • EPS Growth
  • BDTX N/A
  • RMR N/A
  • EPS
  • BDTX 0.38
  • RMR 1.03
  • Revenue
  • BDTX $70,000,000.00
  • RMR $196,824,000.00
  • Revenue This Year
  • BDTX N/A
  • RMR $320.23
  • Revenue Next Year
  • BDTX N/A
  • RMR N/A
  • P/E Ratio
  • BDTX $10.20
  • RMR $14.55
  • Revenue Growth
  • BDTX N/A
  • RMR N/A
  • 52 Week Low
  • BDTX $1.20
  • RMR $13.48
  • 52 Week High
  • BDTX $4.94
  • RMR $22.60
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 46.51
  • RMR 44.08
  • Support Level
  • BDTX $3.67
  • RMR $14.84
  • Resistance Level
  • BDTX $4.06
  • RMR $15.66
  • Average True Range (ATR)
  • BDTX 0.32
  • RMR 0.47
  • MACD
  • BDTX -0.06
  • RMR -0.03
  • Stochastic Oscillator
  • BDTX 13.95
  • RMR 10.34

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

Share on Social Networks: